Disclosed is a method of treatment or prevention of frailty in an elderly patient particularly having an age of 60 or older. The method provides the concomitant parenteral administration of a combination of an anabolic steroid and a vitamin D compound. A preferred combination comprises nandrolone decanoate and cholecalciferol (Vitamin D 3 ). The invention in a further preference provides a booster therapy to support frail elderly that have undergone hospitalization or surgery to retain independe...

596057 Disclosed is a pharmaceutical composition comprising an anabolic steroid (such as oxymetholone oxandrolone nandrolone and esters thereof such as nandrolone decanoate) and a vitamin D compound (such as ergocalciferol cholecalciferol calcidiol calcitriol doxercalciferol or calcipotriene) in a carrier liquid wherein the composition is adapted for parenteral administration. Further disclosed is the use of an anabolic steroid and a vitamin D compound in the manufacture of a parenteral composit...

Disclosed is a method of treatment or prevention of frailty in an elderly patient particularly having an age of 60 or older.The method provides the concomitant parenteral administration of a combination of an anabolic steroid and a vitamin D compound.A preferred combination comprises nandrolone decanoate and cholecalciferol (Vitamin D 3 ).The invention in a further preference provides a booster therapy to support frail elderly that have undergone hospitalization or surgery to retain independence...

Disclosed is a method of treatment or prevention of frailty in an elderly patient, particularly having an age of 60 or older. The method provides the concomitant parenteral administration of a combination of an anabolic steroid and a vitamin D compound. A preferred combination comprises nandrolone decanoate and cholecalciferol (vitamin D3). The invention, in a further preference, provides a booster therapy to support frail elderly that have undergone hospitalization or surgery to retain independ...

Disclosed is a method of treatment or prevention of frailty in an elderly patient particularly having an age of 60 or older. The method provides the concomitant parenteral administration of a combination of an anabolic steroid and a vitamin D compound. A preferred combination comprises nandrolone decanoate and cholecalciferol (vitamin D3). The invention in a further preference provides a booster therapy to support frail elderly that have undergone hospitalization or surgery to retain independenc...

Disclosed is a method of treatment or prevention of frailty in an elderly patient particularly having an age of 60 or older. The method provides the concomitant parenteral administration of a combination of an anabolic steroid and a vitamin D compound. A preferred combination comprises nandrolone decanoate and cholecalciferol (vitamin D3). The invention in a further preference provides a booster therapy to support frail elderly that have undergone hospitalization or surgery to retain independenc...

Disclosed is a method of treatment or prevention of frailty in an elderly patient particularly having an age of 60 or older. The method provides the concomitant parenteral administration of a combination of an anabolic steroid and a vitamin D compound. A preferred combination comprises nandrolone decanoate and cholecalciferol (vitamin D). The invention in a further preference provides a booster therapy to support frail elderly that have undergone hospitalization or surgery to retain independence...

Disclosed is a method of treatment or prevention of frailty in an elderly patient particularly having an age of 60 or older. The method provides the concomitant parenteral administration of a combination of an anabolic steroid and a vitamin D compound. A preferred combination comprises nandrolone decanoate and cholecalciferol (vitamin D3). The invention in a further preference provides a booster therapy to support frail elderly that have undergone hospitalization or surgery to retain independenc...

Disclosed is a method of treatment or prevention of frailty in an elderly patient particularly having an age of 60 or older. The method provides the concomitant parenteral administration of a combination of an anabolic steroid and a vitamin D compound. A preferred combination comprises nandrolone decanoate and cholecalciferol (vitamin D.sub.3). The invention in a further preference provides a booster therapy to support frail elderly that have undergone hospitalization or surgery to retain indepe...